UK researchers are making significant progress on a novel Ebola vaccine, with potential trials anticipated within months. The focus is on a specific, rare strain of the virus called Bundibugyo. This particular Ebola variant carries a mortality rate of approximately one-third for infected individuals, and currently, there is no established vaccine for it. The development by these scientists represents a crucial step forward in addressing this public health threat.


